India Glycols Limited has announced the transfer of Shri Akshay Bansal, Head- Sales & Marketing of its Ennature Biopharma Division, to Ennature Bio Pharma Limited (EBL), a wholly-owned subsidiary. Consequently, Mr. Bansal has ceased to be a Senior Managerial Personnel (SMP) of India Glycols Limited as of July 30, 2026. He has simultaneously been appointed as an Additional Director (Executive Director) & Key Managerial Personnel (KMP) at EBL.
Senior Management Transition
India Glycols Limited (IGL) has informed exchanges about a material update concerning its senior managerial personnel. Shri Akshay Bansal, who held the position of Head- Sales & Marketing for the Ennature Biopharma Division at IGL, has been transferred to Ennature Bio Pharma Limited (EBL), a wholly-owned subsidiary. This transition means that Mr. Bansal is no longer considered a Senior Managerial Personnel (SMP) of India Glycols Limited, effective from the close of business hours on July 30, 2026.
Appointment at Subsidiary
In line with this transfer, EBL has appointed Shri Akshay Bansal as an Additional Director, holding the role of Executive Director, and as a Key Managerial Personnel (KMP). This appointment at EBL is effective from July 31, 2026, and is for a term of five consecutive years, concluding on July 30, 2031, subject to shareholder approval. Mr. Bansal’s profile indicates 26 years of experience in pharmaceuticals, nutraceuticals, and nicotine industries, with prior roles including Head Sales & Marketing at IGL’s Ennature Bio Pharma Division.
Disclosure Details
The disclosure is made in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and pertains to a material update concerning the Scheme of Arrangement involving India Glycols Limited, Ennature Bio Pharma Limited, and IGL Spirits Limited. The necessary details regarding Mr. Bansal’s appointment at EBL are provided as per regulatory requirements and relevant circulars issued by the stock exchanges.
Source: BSE
